Pre-market
Loading markets…

Advertisement

Stocks/TSX/BCT

Briacell Therapeutics Corp (BCT : TSX)

Common Stock

$4.86

CAD

+0.05 (1.04%)

Last updated: 2026-10-20

Follow BCT

BCT

Briacell Therapeutics Corp

Source:WealthAwesomeWealthAwesome
↑ $0.01 (0.21%)
30 day period
$4.81$5.46$6.10Sep 8Sep 29Oct 20

Performance

1 Day

+1.04%

1 Week

-8.47%

1 Month

-17.77%

YTD

-50.51%

Key Statistics

Market Cap

$41.85M

52W High

$19.24

52W Low

$3.68

P/E Ratio

-

50 Day MA

$5.30

200 Day MA

$5.53

Beta

1.51

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

↓Below 50 SMA

Price vs 200-Day SMA

↓Below 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
10/20/2026$4.78$5.05$4.77$4.86$4.864,000
10/19/2026$4.86$4.87$4.81$4.81$4.811,926
10/16/2026$5.41$5.41$4.80$4.88$4.8815,457
10/15/2026$5.26$5.36$5.26$5.36$5.36891
10/14/2026$5.38$5.50$5.25$5.25$5.252,967
10/13/2026$5.56$5.56$5.30$5.31$5.314,304
10/9/2026$5.56$5.66$5.56$5.61$5.611,100
10/8/2026$5.57$5.62$5.55$5.56$5.564,042
10/7/2026$5.70$5.73$5.63$5.69$5.691,723
10/6/2026$5.92$5.92$5.67$5.70$5.703,627

Analyst Price Targets

Based on analyst covering BCT · as of Sep 17, 2026

📈

Wall Street analysts forecast BCT stock price to rise 311.5% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$20.00

+311.5% Upside

Current Price

C$4.86

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on BCT's historical volatility

HistoricalForecast68%95%
C$1.79C$3.56C$5.34C$7.11C$8.89C$10.67TodayJun 11Aug 17Oct 20Dec 2Jan 15Feb 27

30-Day Vol

72.3%

Annualized

90-Day Vol

70.9%

Annualized

Trend (90d)

-30.0%

Annualized drift

90d Mean

C$4.37

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$4.69C$3.65 – C$6.02
60 trading daysC$4.52C$3.18 – C$6.44
90 trading daysC$4.37C$2.83 – C$6.72

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Briacell Therapeutics Corp

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate theclinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.

Financials

Revenue (TTM)
$0
EBITDA
$-31.92M
Profit Margin
0.00%
ROE (TTM)
-175.26%
EPS (Diluted)
-1.27
Book Value
4.69

Classification

Sector
Health Care
Industry
Biotechnology
Group
Pharmaceuticals, Biotechnology & Life Sciences

🔄 Recent Splits

1-for-10

Aug 25, 2025

Reverse

1-for-15

Jan 29, 2025

Reverse

1009-for-1000

Sep 5, 2023

Split

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About BCT

Market movers

Recent TSX movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
AABAberdeen International Inc.$0.03+25.00%
TXPTouchstone Exploration Inc$0.20+14.71%
CNTCentury Global Commodities Corp$0.04+14.29%
ELEFSilver Elephant Mining Corp$0.17+9.37%
XMF-AM Split Corp$1.80+9.09%
EPRXEupraxia Pharmaceuticals Inc$10.72+9.05%
AVNTAvant Brands Inc$0.54+8.00%
BBBlackBerry Ltd$12.45+7.89%

BCT.TO news timeline

15 articles covering BCT.TO, most recent first

Latest

Why Briacell Therapeutics Corp stock is sliding today

•Stocks

Advertisement